Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Filippo Gherlinzoni

1-50 of 86 results

View this query on the Wikidata Query Service
Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe

scientific article
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

scientific article published on 03 August 2011
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

scientific article published in April 2003
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients

scientific article
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

article by Gabriele Gugliotta et al published 26 May 2011 in Blood
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

scientific article
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

scientific article published in March 1994
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma

article by P L Zinzani et al published February 2000 in Journal of Clinical Oncology
Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series.

scientific article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib

scientific article published on 2 May 2017
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

scientific article published on 01 November 2014
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

scientific article
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

scientific article
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.

scientific article
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

scientific article
Imatinib and hyperlipidemia

scientific article published in December 2005
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia

scientific article published on 16 November 2011
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy

scientific article published on 01 August 1998
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.

scientific article published in September 2002
Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones

scientific article published on 01 May 2006
Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

scientific article published in September 2008
Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.

scientific article published on 03 February 2014
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia

scientific article published on 11 August 2013
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

scientific article published on 14 January 2015
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas

scientific article published on 01 January 1991
Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM)

scientific article published on 01 May 1988
Primary cardiac onset of disseminated Burkitt's lymphoma

scientific article published on 8 December 2007
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas

scientific article
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

scientific article published on 13 August 2020
Flai (fludarabine, cytarabine, idarubicin) plus low-dose gemtuzumab ozogamicin as induction therapy in cd33-positive aml: Final results and long term outcome of a phase ii multicenter clinical trial

scientific article
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

scientific article published on 3 August 2017
Babesia infection in Italy

scientific article published in April 2004
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

scientific article published on 01 November 1999
Meningitis and septicaemia in adults splenectomized for Hodgkin's disease

scientific article published in May 1986
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

scientific article published on 23 May 2017
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.

scientific article published on 26 September 2017
Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells

scientific article published on 2 February 2016
3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas

scientific article published in January 1997
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.

scientific article published on 14 February 2017
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

scientific article published in February 2004
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report

scientific article published in December 1990
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies

scientific article published on 01 November 1988
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories

scientific article published on 6 March 2017
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

scientific article published on 29 May 2018
Aleukemic granulocytic sarcoma with associated T-cell lymphoblastic lymphoma in the same lymph node: morphologic features and molecular signatures

scientific article published on 01 July 2008
Psychological screening of onco-hematologic inpatients: Distress Thermometer administration

scientific article published on 5 October 2015
VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly

scientific article published on 01 November 1993
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology

scientific article published in December 1990
High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma

scientific article
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

scientific article

Paulina is supported by:

About Paulina

Help